White Paper

Prediabetes: a nutraceutical from Biofarma to counteract it

Format: PDF file | Document type: White Paper | Promoted Content

This content is provided by Biofarma Group, and any views and opinions expressed do not necessarily reflect those of www.nutraingredients.com

Prediabetes: a nutraceutical from Biofarma to counteract it

Diabetes is a major health issue that has reached alarming levels. Biofarma Group has developed Reglicem, an innovative clinically validated nutraceutical product able to reduce IFG (fasting blood glucose) and IGT (fast glucose tolerance) values in patients with prediabetes conditions.
These effects are made possible thanks to the action of turmeric (Curcuma longa), barberry (Berberis vulgaris), banaba (Lagerstroemia speciosa), inositol, and chromium, whose effectiveness is proven and supported by scientific evidence.

Latest content from Biofarma Group

show more

Using nutrigenomics to improve active ingredients in supplements

Paid for and content provided by Biofarma Group

Nutrigenomics: The future of healthy living?

Nutrigenomics can improve traditional limitations when developing dietary supplements by targeting specific active ingredients to promote efficacy and adaptability.

Related resources from Biofarma Group

Show more

Supplier info centre